Download Antiviral Drug Discovery for Emerging Diseases and by Paul F. Torrence PDF
By Paul F. Torrence
Antiviral Drug Discovery provides readers a state-of-the-art view of ways chemical thoughts are being mobilized to strengthen novel techniques that would successfully confront rising illnesses and biowarfare. one of the subject matters mentioned are smallpox, the Ebola virus, influenza, SARS, arenaviruses and flaviviruses. each one bankruptcy discusses hypothetical concepts for the invention of proper antiviral brokers, contemporary findings regarding biochemistry or drug discovery, and advances within the extra improvement of tested leads within the sector. well timed and informative, this booklet sincerely delineates the efforts being made to boost new and potent broad-spectrum antiviral brokers.
Read or Download Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats PDF
Best viral books
''Offering study and evidence-based guidance for strategic plan improvement, this booklet attracts at the classes realized over 3 years of pandemic preparedness routines. taking part with nationwide leaders and neighborhood stakeholders, the contributing authors research preparedness throughout quite a few institutional degrees and view the problems and matters which may come up during the method.
Practice the latest techniques to guage microbial susceptibility. Antibiotics in Laboratory Medicine has been the defining reference resource on comparing the effectiveness of antibiotic compounds in treating infectious ailments for over 35 years. This completely up-to-date sixth version, edited via Daniel Amsterdam and that includes contributions from an elite workforce of top overseas specialists, equips you with all the most recent methods for reading the mechanisms of activity/resistance of quite a few pathogens, assessing their susceptibility to potential remedies, and detecting drug resistance and multi-drug resistance.
Regardless of being well-known and fought opposed to over numerous centuries, human viral pathogens proceed to reason significant public illnesses worldwide―killing thousands of individuals and costing billions of bucks in remedy and misplaced productiveness every year. With contributions from experts of their respective parts of viral pathogen study, Molecular Detection of Human Viral Pathogens presents a competent reference on molecular detection and identity of significant human viral pathogens.
- The Official Patient's Sourcebook on Genital Candidiasis: A Revised and Updated Directory for the Internet Age
- Hepatitis C Virus: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References
- The Official Patient's Sourcebook on Group B Streptococcus Infection: A Revised and Updated Directory for the Internet Age
- Plant Virology Protocols: From Virus Isolation to Transgenic Resistance (Methods in Molecular Biology)
- Advancing Prion Science: Guidance for the National Prion Research Program
Extra info for Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats
Antiviral Res. 2003, 57, 25–33. 28 VIRAL BIOTERRORISM AND ANTIVIRAL COUNTERMEASURES 31. ; Roy, C. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir. Antiviral Res. 2002, 54, 129–142. 32. ; Bray, M. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrob. Agents Chemother. 2003, 47, 2933–2937. 33. Kern, E. ; Beadle, J. ; Hostetler, K. Y. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
G. ), ASM Press, Washington, DC, 2002, pp. 875–890. 27. Bray, M. Defense against filoviruses used as biological weapons. Antiviral Res. 2003, 57, 53–60. 28. Anonymous. Infection control for viral hemorrhagic fevers in the African health care setting. Centers for Disease Control and Prevention, Atlanta, 1998. 29. Baker, R. ; Huggins, J. W. Potential antiviral therapeutics for smallpox and other orthopoxvirus infections. Antiviral Res. 2003, 57, 13–23. 30. ; De Clercq, E. Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives.
SKH-1 hairless mice (immunocompetent or immunosuppressed) readily became infected with either vaccinia or cowpox when virus was applied to abraded skin. 162,163 Huggins and co-workers reported that cynomolgus monkeys infected with monkeypox either by small-particle aerosol or by intravenous inoculation developed classical poxvirus lesions and pulmonary distress, while one model using intravenous variola produced a similar lesional disease and 33% mortality. CDV prophylaxis was completely protective.